Steven Romick - First Pacific Advisors
Holding/activity history for Theravance Biopharma, Inc. (TBPH)
← All TBPH superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2022 Q3 | 0 | 0.00 | Sell 100.00% | 0.02 | $7.53–11.00 · VW $9.13i | SEC | |
| 2022 Q2 | 176,539 | 0.02 | Add 26.30% | <0.01 | $8.15–10.52 · VW $9.23i | $1,599,000 | SEC |
| 2022 Q1 | 139,774 | 0.02 | Buy | 0.02 | $7.71–13.17 · VW $9.89i | $1,336,000 | SEC |
Price snapshot:
Current price$16.90
52-week low$10.82
52-week high$21.03